Back to search

United States· US:68163-517_e05e76f9-c391-452e-93eb-82cca563845e

DRx Choice Fiber Therapy

A medicinal product containing methylcellulose (4000 mpa.s), registered in United States by RARITAN PHARMACEUTICALS INC.

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedDRx Choice Fiber TherapyATC—REGISTER NO.US:68163-517_e05e76f9…PACKS LISTED1CHECKEDSeptember 27, 2026

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
METHYLCELLULOSE (4000 MPA.S)
Manufacturer
RARITAN PHARMACEUTICALS INC
Country
United States (US)
ATC code
—
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 27, 2026

Packs & prices · 1

  • ndc11
    68163-517-16

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/fae5b734-4dca-4040-b8c1-d61ef2c3aab2
GET /v1/drugs/fae5b734-4dca-4040-b8c1-d61ef2c3aab2?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "ORAL",
  "source": "ndc",
  "strength": "2",
  "substance": "METHYLCELLULOSE (4000 MPA.S)",
  "productndc": "68163-517",
  "dosage_form": "POWDER, FOR SOLUTION",
  "dea_schedule": null,
  "strength_unit": "g/10.2g",
  "application_number": "M007",
  "marketing_category": "OTC MONOGRAPH DRUG"
}

See everything about methylcellulose (4000 mpa.s).

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.